A critical advance in cancer study is emerging with the use of nanobodies to restore damaged p53. This essential tumor inhibitor protein is frequently disabled in several kinds of tumors, resulting uncontrolled cell https://socialtechnet.com/story7551495/mini-antibodies-restore-tumor-suppressor-p53-a-new-hope-for-cancer-management